Search

everythinglearnresearchcommunity

for

Search:↓

Older men with postoperative urinary retention are more likely to need future bladder procedures.

Many patients with lower urinary tract symptoms also have undiagnosed erectile dysfunction, which improves with treatment.

Treatments for enlarged prostate can cause problems with ejaculation, and less invasive options might preserve sexual function better.

Polypoid cystitis can mimic bladder cancer but can be effectively treated with surgery, stents, and medication.

Nocturia cases increased, but medication use declined, suggesting under-treatment.

Botulinum toxin type A reduces itch and inflammation from histamine and may help treat certain skin conditions and hair loss.

Botulinum toxin A helped stop hair loss and grow new hair in mice.

The doxazosin plus tamsulosin combination improved symptoms effectively with fewer side effects.

Dual therapy with specific medications can help manage male urinary symptoms and reduce side effects.

A bladder rupture from prostate treatment was healed with catheterization and antibiotics.

Teaching men with simple bladder problems self-management skills can improve their symptoms and quality of life.

Dutasteride can reduce night-time urination but it doesn't improve sleep quality.

AMN can cause bladder problems due to nerve damage.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Treatment for benign prostatic hyperplasia involves drugs that either quickly relieve symptoms or reduce prostate size, with a combination offering more benefits but more side effects.

Both dutasteride and finasteride improve urinary symptoms, but dutasteride may be better at reducing the risk of prostate surgery and sudden inability to urinate.

Post-void residual volume does not predict worsening urological symptoms in multiple sclerosis patients.

Dutasteride, fesoterodine, and finasteride help older patients with urinary issues.

Dutasteride, fesoterodine, and finasteride are beneficial for older patients, while most other drugs should be used cautiously or avoided.

New BPH treatments have low sexual dysfunction risk but may not improve urinary symptoms as much as traditional surgery.

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

Dutasteride is more effective than finasteride in reducing urinary retention and surgery risks in people aged 65 and older.

Medications improve quality of life for men with lower urinary tract symptoms.

Higher CRP levels suggest chronic inflammation is linked to bladder-related urinary symptoms in men with enlarged prostates.

Improving prostate and urinary health can enhance sexual function and mental well-being in older men.

Taking dutasteride for one month before prostate surgery can reduce bleeding.

Researchers created a simple tool to predict bladder blockage from prostate enlargement using urine flow rate and prostate volume.

Using mirabegron and solifenacin together is safe and more effective for treating overactive bladder than using either drug alone.

Doctors should adjust how they treat men with prostate-related urinary problems during and after the COVID-19 pandemic.

Dutasteride is linked to a higher chance of sexual dysfunction, especially in younger males and the elderly.